Intelligent bio solutions subsidiary broadens intellectual property portfolio with grant of new european patent with unitary effect for innovative intelligent fingerprinting dsr-plus cartridge reader

New york, april 11, 2024 (globe newswire) -- intelligent bio solutions inc. (“inbs” or the “company”) (nasdaq: inbs), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the broadening of the intellectual property portfolio of its wholly owned subsidiary, intelligent fingerprinting limited, with the grant of a new european patent with unitary effect for its ground-breaking dsr-plus cartridge reader. this latest achievement follows the successful protection of the same technology in the united kingdom and marks another significant milestone in the company's expansion and protection of its intellectual property.
INBS Ratings Summary
INBS Quant Ranking